GLP-1 Antagonists

Type: Concept

As of November 2026, GLP-1 Antagonists has been mentioned in one podcast episode on The Diary Of A CEO (Oct 2025). Discussed as a treatment option for weight management and insulin resistance.

Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 agonists, GLP-1RAs, and informally as simply GLP-1s, are a class of medications that activate the GLP-1 receptor, causing reduced blood sugar, reduced appetite, and reduced energy intake. GLP-1 analogs are molecules that are structurally almost identical to the endogenous GLP-1 hormone. Incretin mimetics are substances that mimic the actions of incretin hormones such as GLP-1 and GIP.